EA
SRRA

Ellsworth Advisors’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Ellsworth Advisors’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,427
Closed -$738K – 156
2022
Q2 		$738K Sell
13,427
-282
-2% -$14.8K 0.3% 66
2022
Q1 		$748K Buy
+13,709
New +$393K 0.26% 70

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

Ellsworth Advisors's SRRA Position: Q3 2022 in Review

Ellsworth Advisors sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 13,427 shares — an estimated $738K sold.

Ellsworth Advisors first reported a position in SRRA in Q1 2022 and held it in 2 quarters. The position peaked at $748K in Q1 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Ellsworth Advisors reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Ellsworth Advisors sold 13,427 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $738K.
  • Ellsworth Advisors first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Ellsworth Advisors's Sierra Oncology, Inc. Common Stock position peaked at $748K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Ellsworth Advisors's 13F filing for Q3 2022, filed 20 Oct 2022.